Zobrazit minimální záznam

Reprogramming of the developing heart by Hif1a-deficient sympathetic system and maternal diabetes exposure

dc.contributor.authorKolesová, Hana
dc.contributor.authorHrabalová, Petra
dc.contributor.authorBohuslavova, Romana
dc.contributor.authorAbaffy, Pavel
dc.contributor.authorFabriciova, Valeria
dc.contributor.authorSedmera, David
dc.contributor.authorPavlinkova, Gabriela
dc.date.accessioned2024-03-07T08:10:33Z
dc.date.available2024-03-07T08:10:33Z
dc.date.issued2024
dc.identifier.urihttps://hdl.handle.net/20.500.14178/2369
dc.description.abstractIntroduction: Maternal diabetes is a recognized risk factor for both short-term and long-term complications in offspring. Beyond the direct teratogenicity of maternal diabetes, the intrauterine environment can influence the offspring's cardiovascular health. Abnormalities in the cardiac sympathetic system are implicated in conditions such as sudden infant death syndrome, cardiac arrhythmic death, heart failure, and certain congenital heart defects in children from diabetic pregnancies. However, the mechanisms by which maternal diabetes affects the development of the cardiac sympathetic system and, consequently, heightens health risks and predisposes to cardiovascular disease remain poorly understood. Methods and results: In the mouse model, we performed a comprehensive analysis of the combined impact of a Hif1a-deficient sympathetic system and the maternal diabetes environment on both heart development and the formation of the cardiac sympathetic system. The synergic negative effect of exposure to maternal diabetes and Hif1a deficiency resulted in the most pronounced deficit in cardiac sympathetic innervation and the development of the adrenal medulla. Abnormalities in the cardiac sympathetic system were accompanied by a smaller heart, reduced ventricular wall thickness, and dilated subepicardial veins and coronary arteries in the myocardium, along with anomalies in the branching and connections of the main coronary arteries. Transcriptional profiling by RNA sequencing (RNA-seq) revealed significant transcriptome changes in Hif1a-deficient sympathetic neurons, primarily associated with cell cycle regulation, proliferation, and mitosis, explaining the shrinkage of the sympathetic neuron population. Discussion: Our data demonstrate that a failure to adequately activate the HIF-1α regulatory pathway, particularly in the context of maternal diabetes, may contribute to abnormalities in the cardiac sympathetic system. In conclusion, our findings indicate that the interplay between deficiencies in the cardiac sympathetic system and subtle structural alternations in the vasculature, microvasculature, and myocardium during heart development not only increases the risk of cardiovascular disease but also diminishes the adaptability to the stress associated with the transition to extrauterine life, thus increasing the risk of neonatal death.en
dc.language.isoen
dc.relation.urlhttps://doi.org/10.3389/fendo.2024.1344074
dc.rightsCreative Commons Uveďte původ 4.0 Internationalcs
dc.rightsCreative Commons Attribution 4.0 Internationalen
dc.titleReprogramming of the developing heart by Hif1a-deficient sympathetic system and maternal diabetes exposureen
dcterms.accessRightsopenAccess
dcterms.licensehttps://creativecommons.org/licenses/by/4.0/legalcode
dc.date.updated2024-05-07T12:40:42Z
dc.subject.keywordmouse modelen
dc.subject.keywordmaternal diabetesen
dc.subject.keywordcoronary arteriesen
dc.subject.keywordsympathetic neuronsen
dc.subject.keywordcardiac sympathetic systemen
dc.identifier.eissn1664-2392
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/MSM//LX22NPO5104
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/UK/GAUK/GAUK160122
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/MSM/LM/LM2018129
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/MSM/EF/EF18_046/0016045
dc.date.embargoStartDate2024-05-07
dc.type.obd73
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.identifier.doi10.3389/fendo.2024.1344074
dc.identifier.utWos001186659800001
dc.identifier.eidScopus2-s2.0-85188125317
dc.identifier.obd645927
dc.identifier.pubmed38505753
dc.subject.rivPrimary30000::30100::30106
dcterms.isPartOf.nameFrontiers in Endocrinology
dcterms.isPartOf.issn1664-2392
dcterms.isPartOf.journalYear2024
dcterms.isPartOf.journalVolume15
dcterms.isPartOf.journalIssueMarch
uk.faculty.primaryId108
uk.faculty.primaryName1. lékařská fakultacs
uk.faculty.primaryNameFirst Faculty of Medicineen
uk.faculty.secondaryId115
uk.faculty.secondaryNamePřírodovědecká fakultacs
uk.faculty.secondaryNameFaculty of Scienceen
uk.department.primaryId1488
uk.department.primaryNameAnatomický ústav 1. LF UKcs
uk.department.primaryNameInstitute of Anatomyen
uk.department.secondaryId1034
uk.department.secondaryId1035
uk.department.secondaryNameKatedra genetiky a mikrobiologiecs
uk.department.secondaryNameDepartment of Genetics and Microbiologyen
uk.department.secondaryNameKatedra buněčné biologiecs
uk.department.secondaryNameDepartment of Cell Biologyen
dc.type.obdHierarchyCsČLÁNEK V ČASOPISU::článek v časopisu::původní článekcs
dc.type.obdHierarchyEnJOURNAL ARTICLE::journal article::original articleen
dc.type.obdHierarchyCode73::152::206en
uk.displayTitleReprogramming of the developing heart by Hif1a-deficient sympathetic system and maternal diabetes exposureen


Soubory tohoto záznamu

Thumbnail

Tento záznam se objevuje v následujících kolekcích

Zobrazit minimální záznam